Diamond Biofund Statistics

Total Valuation

Diamond Biofund has a market cap or net worth of TWD 26.90 billion. The enterprise value is 21.03 billion.

Market Cap	26.90B
Enterprise Value	21.03B

Important Dates

The last earnings date was Tuesday, February 25, 2025.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Diamond Biofund has 851.39 million shares outstanding. The number of shares has increased by 12.81% in one year.

Current Share Class	n/a
Shares Outstanding	851.39M
Shares Change (YoY)	+12.81%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	25.25%
Owned by Institutions (%)	5.18%
Float	179.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.42
P/TBV Ratio	2.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.47
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.70

Financial Position

The company has a current ratio of 69.93, with a Debt / Equity ratio of 0.01.

Current Ratio	69.93
Quick Ratio	69.91
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-432.10

Financial Efficiency

Return on equity (ROE) is -13.12% and return on invested capital (ROIC) is -8.25%.

Return on Equity (ROE)	-13.12%
Return on Assets (ROA)	-8.21%
Return on Invested Capital (ROIC)	-8.25%
Return on Capital Employed (ROCE)	-14.05%
Revenue Per Employee	-50.24M
Profits Per Employee	-55.75M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.11% in the last 52 weeks. The beta is 1.51, so Diamond Biofund's price volatility has been higher than the market average.

Beta (5Y)	1.51
52-Week Price Change	-25.11%
50-Day Moving Average	32.43
200-Day Moving Average	37.70
Relative Strength Index (RSI)	38.73
Average Volume (20 Days)	481,632

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diamond Biofund had revenue of TWD -1.41 billion and -1.56 billion in losses. Loss per share was -1.84.

Revenue	-1.41B
Gross Profit	-1.41B
Operating Income	-1.58B
Pretax Income	-1.56B
Net Income	-1.56B
EBITDA	-1.57B
EBIT	-1.58B
Loss Per Share	-1.84

Full Income Statement

Balance Sheet

The company has 6.00 billion in cash and 123.70 million in debt, giving a net cash position of 5.88 billion or 6.90 per share.

Cash & Cash Equivalents	6.00B
Total Debt	123.70M
Net Cash	5.88B
Net Cash Per Share	6.90
Equity (Book Value)	11.13B
Book Value Per Share	13.08
Working Capital	5.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.44 billion and capital expenditures -32.88 million, giving a free cash flow of -4.47 billion.

Operating Cash Flow	-4.44B
Capital Expenditures	-32.88M
Free Cash Flow	-4.47B
FCF Per Share	-5.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	112.15%
Pretax Margin	110.97%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Diamond Biofund does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.81%
Shareholder Yield	-12.81%
Earnings Yield	-5.80%
FCF Yield	-16.62%

Dividend Details

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 1.18.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	1.18

Scores

Diamond Biofund has an Altman Z-Score of 116.88.

Altman Z-Score	116.88
Piotroski F-Score	n/a